1. Home
  2. BBLG vs VRAX Comparison

BBLG vs VRAX Comparison

Compare BBLG & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBLG

Bone Biologics Corp

HOLD

Current Price

$0.41

Market Cap

1.2M

Sector

Health Care

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$1.32

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBLG
VRAX
Founded
2004
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2M
972.3K
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
BBLG
VRAX
Price
$0.41
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.2K
★ 152.5K
Earning Date
10-26-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 45.13
N/A
EPS
N/A
★ N/A
Revenue
★ $1,070,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.10
52 Week High
$4.78
$13.19

Technical Indicators

Market Signals
Indicator
BBLG
VRAX
Relative Strength Index (RSI) 24.16 28.53
Support Level $0.38 $0.15
Resistance Level $1.18 $2.92
Average True Range (ATR) 0.03 0.15
MACD 0.03 -0.01
Stochastic Oscillator 26.19 21.07

Price Performance

Historical Comparison
BBLG
VRAX

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: